Albuterol Sulfate Aerosol, Metered
Product Images NDC 76420-088
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 76420-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure F (Albuterol Sulfate Hfa N021457 10)
Figure G (Albuterol Sulfate Hfa N021457 11)
Figure H (Albuterol Sulfate Hfa N021457 12)
Figure I (Albuterol Sulfate Hfa N021457 13)
Figure J (Albuterol Sulfate Hfa N021457 14)
Figure K (Albuterol Sulfate Hfa N021457 15)
Albuterol Sulfate Hfa Inhalation Aerosol 90 Mcg Per Actuation, 200 Metered Inhalations Carton (Albuterol Sulfate Hfa N021457 16)
This is a description of Albuterol Sulfate HFA Inhalation Aerosol, a prescription drug marketed by Teva Pharmaceuticals USA, Inc. It is a metered dose inhaler with a drug strength of 90mcg. The drug is relabeled by Enovachem and has a lot number and batch number, with expiration details mentioned. The drug is available in a quantity of one and cannot be dispensed without a prescription due to federal law. The drug needs to be stored within a temperature range of 20-25C (68-77F). The text repeats the drug's NDC number and mentions a SIN.*
Day 1 Image (Albuterol Sulfate Hfa N021457 2)
This appears to be a chart or table displaying data related to the effectiveness of different inhalers for treating respiratory issues. The chart appears to show the results for three different treatments: Albuterol Sulfate HFA Inhalation Aerosol, Matched Placebo HFA Inhalation Aerosol, and a Marketed HFA-134a Albuterol Inhaler. The data is displayed in a table with columns for the number of participants (N) in each treatment group, as well as a chart displaying the percentage change in FEV (forced expiratory volume) over time (measured in hours). Without more context, it is difficult to provide a more specific interpretation of the data.*
Day 43 Image (Albuterol Sulfate Hfa N021457 3)
Figure A (Albuterol Sulfate Hfa N021457 5)
Figure B (Albuterol Sulfate Hfa N021457 6)
Figure C (Albuterol Sulfate Hfa N021457 7)
Figure D (Albuterol Sulfate Hfa N021457 8)
Figure E (Albuterol Sulfate Hfa N021457 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.